Kalvista Long Term Debt Total vs Deferred Long Term Liab Analysis

KALV Stock  USD 9.44  0.10  1.07%   
Kalvista Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Kalvista Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kalvista Pharmaceuticals is a good investment. Please check the relationship between Kalvista Pharmaceuticals Long Term Debt Total and its Deferred Long Term Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kalvista Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.

Long Term Debt Total vs Deferred Long Term Liab

Long Term Debt Total vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kalvista Pharmaceuticals Long Term Debt Total account and Deferred Long Term Liab. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Kalvista Pharmaceuticals' Long Term Debt Total and Deferred Long Term Liab is -0.31. Overlapping area represents the amount of variation of Long Term Debt Total that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Kalvista Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Kalvista Pharmaceuticals' Long Term Debt Total and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt Total of Kalvista Pharmaceuticals are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Long Term Debt Total i.e., Kalvista Pharmaceuticals' Long Term Debt Total and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.31
Relationship DirectionNegative 
Relationship StrengthInsignificant

Long Term Debt Total

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.
Most indicators from Kalvista Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kalvista Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kalvista Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.Enterprise Value is likely to climb to about 131.3 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.9 M in 2024.
 2023 2024 (projected)
Net Interest Income3.9M4.1M
Non Recurring1.3M1.2M

Kalvista Pharmaceuticals fundamental ratios Correlations

0.570.90.60.990.810.42-0.62-0.820.750.540.79-0.181.00.810.71-0.620.760.93-0.210.921.0-0.520.8-0.320.37
0.570.510.130.560.68-0.18-0.03-0.670.540.220.710.360.560.530.480.00.50.59-0.130.690.550.260.550.230.47
0.90.510.740.880.710.42-0.53-0.940.910.40.7-0.150.880.780.67-0.590.720.97-0.140.940.89-0.480.8-0.310.35
0.60.130.740.560.450.56-0.64-0.650.720.430.45-0.110.580.490.52-0.430.470.670.120.630.59-0.50.53-0.22-0.05
0.990.560.880.560.810.46-0.62-0.80.740.570.8-0.110.990.840.73-0.680.760.91-0.340.890.99-0.550.82-0.240.34
0.810.680.710.450.810.43-0.54-0.790.70.580.99-0.040.790.780.93-0.50.720.79-0.240.840.8-0.390.82-0.140.24
0.42-0.180.420.560.460.43-0.79-0.340.370.580.41-0.260.410.420.55-0.710.360.42-0.380.350.43-0.820.44-0.27-0.59
-0.62-0.03-0.53-0.64-0.62-0.54-0.790.43-0.39-0.84-0.50.33-0.62-0.65-0.520.71-0.35-0.530.21-0.49-0.620.8-0.570.350.27
-0.82-0.67-0.94-0.65-0.8-0.79-0.340.43-0.96-0.38-0.780.08-0.81-0.76-0.740.46-0.66-0.950.06-0.96-0.820.32-0.840.27-0.32
0.750.540.910.720.740.70.37-0.39-0.960.360.70.010.750.710.73-0.480.580.89-0.080.880.75-0.350.83-0.20.24
0.540.220.40.430.570.580.58-0.84-0.380.360.540.010.550.780.57-0.750.260.38-0.420.40.54-0.660.730.0-0.16
0.790.710.70.450.80.990.41-0.5-0.780.70.540.050.770.750.93-0.460.70.77-0.270.830.78-0.320.81-0.050.23
-0.180.36-0.15-0.11-0.11-0.04-0.260.330.080.010.010.05-0.17-0.030.010.2-0.2-0.22-0.46-0.17-0.190.480.060.96-0.05
1.00.560.880.580.990.790.41-0.62-0.810.750.550.77-0.170.80.7-0.610.710.91-0.20.91.0-0.50.79-0.310.36
0.810.530.780.490.840.780.42-0.65-0.760.710.780.75-0.030.80.72-0.820.650.75-0.450.780.81-0.620.95-0.110.31
0.710.480.670.520.730.930.55-0.52-0.740.730.570.930.010.70.72-0.570.590.71-0.280.730.71-0.480.84-0.110.1
-0.620.0-0.59-0.43-0.68-0.5-0.710.710.46-0.48-0.75-0.460.2-0.61-0.82-0.57-0.52-0.530.6-0.49-0.620.92-0.760.220.04
0.760.50.720.470.760.720.36-0.35-0.660.580.260.7-0.20.710.650.59-0.520.75-0.220.790.75-0.450.58-0.230.36
0.930.590.970.670.910.790.42-0.53-0.950.890.380.77-0.220.910.750.71-0.530.75-0.080.980.93-0.440.78-0.390.34
-0.21-0.13-0.140.12-0.34-0.24-0.380.210.06-0.08-0.42-0.27-0.46-0.2-0.45-0.280.6-0.22-0.08-0.06-0.210.35-0.39-0.490.14
0.920.690.940.630.890.840.35-0.49-0.960.880.40.83-0.170.90.780.73-0.490.790.98-0.060.91-0.370.8-0.330.39
1.00.550.890.590.990.80.43-0.62-0.820.750.540.78-0.191.00.810.71-0.620.750.93-0.210.91-0.530.8-0.320.37
-0.520.26-0.48-0.5-0.55-0.39-0.820.80.32-0.35-0.66-0.320.48-0.5-0.62-0.480.92-0.45-0.440.35-0.37-0.53-0.550.460.2
0.80.550.80.530.820.820.44-0.57-0.840.830.730.810.060.790.950.84-0.760.580.78-0.390.80.8-0.55-0.080.26
-0.320.23-0.31-0.22-0.24-0.14-0.270.350.27-0.20.0-0.050.96-0.31-0.11-0.110.22-0.23-0.39-0.49-0.33-0.320.46-0.08-0.1
0.370.470.35-0.050.340.24-0.590.27-0.320.24-0.160.23-0.050.360.310.10.040.360.340.140.390.370.20.26-0.1
Click cells to compare fundamentals

Kalvista Pharmaceuticals Account Relationship Matchups

Kalvista Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets118.1M92.5M272.0M203.9M183.2M235.4M
Short Long Term Debt Total54K1.6M5.9M8.2M8.2M7.3M
Other Current Liab5.5M6.9M7.0M9.1M12.4M29K
Total Current Liabilities18.1M7.7M9.8M11.6M15.0M22.8M
Total Stockholder Equity96.7M83.8M257.2M185.1M161.0M206.6M
Property Plant And Equipment Net3.7M7.5M10.0M10.8M9.1M9.6M
Net Debt(14.1M)(44.7M)(22.5M)(48.0M)(24.5M)(25.7M)
Retained Earnings(92.5M)(121.6M)(167.8M)(250.2M)(343.1M)(469.7M)
Accounts Payable2.9M1.7M2.0M3.6M4.8M9.1M
Cash32.0M15.8M50.6M30.7M56.2M31.8M
Non Current Assets Total3.8M7.7M10.2M10.9M9.7M10.2M
Cash And Short Term Investments100.8M67.7M248.9M166.2M149.4M210.4M
Common Stock Total Equity17K18K24K25K34K18.2K
Common Stock Shares Outstanding17.7M19.1M24.5M27.9M36.8M38.6M
Liabilities And Stockholders Equity92.5M272.0M203.9M183.2M235.4M247.2M
Non Current Liabilities Total1.1M5.0M7.2M7.1M6.0M10.7M
Other Current Assets4.5M3.6M10.6M4.3M4.4M1.0M
Other Stockholder Equity207.2M426.4M439.1M507.1M679.8M(75K)
Total Liab21.4M8.8M14.8M18.8M22.2M28.8M
Property Plant And Equipment Gross2.4M3.7M7.5M10.0M10.8M12.9M
Total Current Assets115.5M88.7M264.3M193.6M172.3M225.7M
Accumulated Other Comprehensive Income(1.9M)(1.9M)(1.4M)(3.9M)(3.1M)(3.5M)
Short Term Debt54K588K863K977K1.1M1.3M
Common Stock17K18K24K25K34K42K
Capital Surpluse191.1M207.2M426.4M439.1M507.1M115.8M
Property Plant Equipment2.4M2.0M1.8M2.2M2.9M1.3M
Net Tangible Assets83.8M257.2M185.1M161.0M43.1M40.9M
Net Receivables11.3M16.5M10.4M14.1M16.6M10.9M
Retained Earnings Total Equity(71.7M)(92.5M)(121.6M)(167.8M)(250.2M)(343.1M)
Short Term Investments68.8M51.9M198.3M135.5M93.1M178.6M
Net Invested Capital83.8M257.2M185.1M161.0M206.6M144.2M
Net Working Capital81.0M254.5M182.1M157.3M202.9M143.4M
Capital Lease Obligations1.6M5.9M8.2M8.2M7.3M4.9M
Capital Stock18K24K25K34K42K29.3K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Kalvista Stock Analysis

When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.